Wynn Capital’s Medtronic MDT Stock Holding History

Wynn Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$417K	Sell	4,833 -25	-0.5%	-$2.2K	0.18%	81
2026 Q2	$380K	Buy	4,858 +225	+5%	+$18.2K	0.17%	85
2026 Q1	$401K	Buy	4,633 +139	+3%	+$13.3K	0.21%	78
2025 Q4	$432K	Sell	4,494 -145	-3%	-$14.1K	0.21%	75
2025 Q3	$442K	Buy	4,639 +110	+2%	+$10.1K	0.21%	78
2025 Q2	$395K	Buy	4,529 +31	+0.7%	+$2.63K	0.21%	81
2025 Q1	$404K	Buy	4,498 +180	+4%	+$16.1K	0.24%	79
2024 Q4	$345K	Buy	4,318 +397	+10%	+$34.4K	0.22%	85
2024 Q3	$353K	Buy	3,921 +640	+20%	+$53.8K	0.23%	87
2024 Q2	$258K	Buy	3,281 +431	+15%	+$35.3K	0.19%	93
2024 Q1	$248K	Buy	2,850 +400	+16%	+$34.1K	0.19%	92
2023 Q4	$202K	Buy	+2,450	New	+$187K	0.16%	101

Other funds holding MDT

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Wynn Capital's MDT Position: Q3 2026 in Review

Wynn Capital reduced its Medtronic (MDT) stake by 0.51% in Q3 2026, selling an estimated $2.2K and leaving 4,833 shares worth $417K. The position accounts for 0.18% of the portfolio, ranked #81.

Wynn Capital first reported a position in MDT in Q4 2023 and has held it in 12 quarters since. The position peaked at $442K in Q3 2025. 1,676 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

Wynn Capital held 4,833 shares of Medtronic worth $417K as of Q3 2026.
Wynn Capital sold 25 Medtronic shares in Q3 2026, an estimated $2.2K.
Medtronic made up 0.18% of Wynn Capital's portfolio in Q3 2026, its #81 holding.
Wynn Capital first reported a position in Medtronic in Q4 2023 and has held it in 12 quarters since.
Wynn Capital's Medtronic position peaked at $442K in Q3 2025.
1,676 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Wynn Capital's 13F filing for Q3 2026, filed 13 Oct 2026.